nelfinavir has been researched along with Carcinoma, Adenoid Cystic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, CM; Buatti, JM; Hoffman, HT; Hoover, AC; Milhem, MM; Smith, BJ; Sun, W | 1 |
| Bodeker, KL; Buatti, JM; Gupta, AK; Hoffman, HT; Milhem, MM; Robinson, RA; Taylor, EN; Wilke, WW | 1 |
1 trial(s) available for nelfinavir and Carcinoma, Adenoid Cystic
| Article | Year |
|---|---|
Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial.
Topics: Adult; Age Factors; Aged; Carcinoma, Adenoid Cystic; Cause of Death; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hospitals, University; Humans; Iowa; Male; Maximum Tolerated Dose; Middle Aged; Nelfinavir; Prospective Studies; Risk Assessment; Salivary Gland Neoplasms; Sex Factors; Survival Rate; Treatment Outcome; United States | 2015 |
1 other study(ies) available for nelfinavir and Carcinoma, Adenoid Cystic
| Article | Year |
|---|---|
Signaling pathways in adenoid cystic cancers: implications for treatment.
Topics: Blotting, Western; Carcinoma, Adenoid Cystic; Cell Line, Tumor; Cell Survival; ErbB Receptors; Head and Neck Neoplasms; HIV Protease Inhibitors; Humans; Immunohistochemistry; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nelfinavir; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Time Factors | 2009 |